|
Under Attack, NVIC Helps Americans Stand Up & Speak Out |
by Barbara Loe Fisher
In 2013, the National Vaccine Information Center (NVIC) enters our fourth decade of preventing vaccine injuries and deaths through public education and defending the legal right to make voluntary vaccination decisions in America.
Each year during the past 30, NVIC has become more successful in achieving our mission. With that success has come more fierce opposition by politically powerful medical trade associations and special interest groups allied with drug companies doing everything they can to censor truthful vaccine information and strip vaccine informed consent protections from public health laws. To watch or read this referenced video commentary and post a comment about how Americans are witnessing the systematic erosion of civil, human and parental rights when it comes to vaccination and health, click here.
NVIC Vaccine Freedom Wall If you have first-hand experience with being threatened, coerced or sanctioned for trying to make informed, voluntary vaccine choices for yourself or your child, please share your story here.
In the News Nov. 29 Hearing on Autism in U.S. House of Representatives: "Will the Autism Hearings in Congress Be Different This Time?" by Anne Dachel, AOA. Nov. 16, 2012. Novartis Bexsero Meningitis Shot Wins EU Agency's Backing by Eva von Schaper, Bloomberg. Nov. 16, 2012 NIH Vaccine Chief Gary Nabel Trades Dream Job for Big Pharmaby Jon Cohen. Science Magazine. Nov. 14, 2012. 10,000 Watchdogs Stand Guard Against the Fluby Julielynn Wong, M.D., Huffington Post. Nov. 13, 2012. Reassessing Flu Shots As the Season Draws Near by Roni Rabin, New York Times. Nov. 5, 2012. |
another vaccine for a two month old??
Quote:Novartis Bexsero Meningitis Shot Wins EU Agency's Backing by Eva von Schaper, Bloomberg. Nov. 16, 2012
Novartis ($NVS) hit a key turning point with its vaccines division when a European Union committee backed the company's Bexsero meningitis shot. The European Medicines Agency's Committee for Medicinal Products for Human Use recommended the granting of marketing authorization to Novartis for Bexsero, saying it should be given to children ages 2 months and older.
Quoting emmy526:another vaccine for a two month old??
Quote:Novartis Bexsero Meningitis Shot Wins EU Agency's Backing by Eva von Schaper, Bloomberg. Nov. 16, 2012
Novartis ($NVS) hit a key turning point with its vaccines division when a European Union committee backed the company's Bexsero meningitis shot. The European Medicines Agency's Committee for Medicinal Products for Human Use recommended the granting of marketing authorization to Novartis for Bexsero, saying it should be given to children ages 2 months and older.
My mom got the
- emmy526
on Nov. 21, 2012 at 10:56 PM